Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor.

[1]  G. Cabral,et al.  Cannabinoid inhibition of the processing of intact lysozyme by macrophages: evidence for CB2 receptor participation. , 1999, The Journal of pharmacology and experimental therapeutics.

[2]  M. Herkenham,et al.  Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[3]  P. Casellas,et al.  Gi protein modulation induced by a selective inverse agonist for the peripheral cannabinoid receptor CB2: implication for intracellular signalization cross-regulation. , 1999, Molecular pharmacology.

[4]  P. Casellas,et al.  SR 144528, an antagonist for the peripheral cannabinoid receptor that behaves as an inverse agonist. , 1999, The Journal of pharmacology and experimental therapeutics.

[5]  M. Parmentier,et al.  Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. , 1999, Science.

[6]  S. Galiègue,et al.  Modulation and functional involvement of CB2 peripheral cannabinoid receptors during B-cell differentiation. , 1998, Blood.

[7]  T. Klein,et al.  Drugs of Abuse, Immunomodulation, and Aids , 1998, Advances in Experimental Medicine and Biology.

[8]  C. Newton,et al.  Cannabinoid receptors and immunity. , 1998, Immunology today.

[9]  T. Klein,et al.  Marijuana, immunity and infection , 1998, Journal of Neuroimmunology.

[10]  P. Casellas,et al.  SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor. , 1998, The Journal of pharmacology and experimental therapeutics.

[11]  V. Lagente,et al.  Influence of fatty acid ethanolamides and delta9-tetrahydrocannabinol on cytokine and arachidonate release by mononuclear cells. , 1997, European journal of pharmacology.

[12]  J. Allison,et al.  Co-stimulation in T cell responses. , 1997, Current opinion in immunology.

[13]  N. Kaminski,et al.  Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system. , 1997, Toxicology and applied pharmacology.

[14]  G. Cabral,et al.  delta 9-Tetrahydrocannabinol selectively inhibits macrophage costimulatory activity and down-regulates heat-stable antigen expression. , 1996, The Journal of pharmacology and experimental therapeutics.

[15]  P. Casellas,et al.  Cannabinoids enhance human B‐cell growth at low nanomolar concentrations , 1995, FEBS letters.

[16]  S. Galiègue,et al.  Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. , 1995, European journal of biochemistry.

[17]  G. Cabral,et al.  delta 9-Tetrahydrocannabinol modulates antigen processing by macrophages. , 1995, The Journal of pharmacology and experimental therapeutics.

[18]  T. Giese,et al.  In CD8+ T cell-deficient lpr/lpr mice, CD4+B220+ and CD4+B220- T cells replace B220+ double-negative T cells as the predominant populations in enlarged lymph nodes. , 1995, Journal of immunology.

[19]  P. Kaye,et al.  Deficient expression of co‐stimulatory molecules on Leishmania‐infected macrophages , 1994, European journal of immunology.

[20]  G. Das,et al.  Macrophage – T cell interaction in experimental mycobacterial infection. Selective regulation of co‐stimulatory molecules on Mycobacterium‐ infected macrophages and its implication in the suppression of cell‐mediated immune response , 1994, European journal of immunology.

[21]  M. Jenkins,et al.  Surface proteins involved in T cell costimulation , 1994, Journal of leukocyte biology.

[22]  A. Enk,et al.  Heat-stable antigen is an important costimulatory molecule on epidermal Langerhans' cells. , 1994, Journal of immunology.

[23]  M. Herkenham,et al.  Localization of cannabinoid receptors and nonsaturable high-density cannabinoid binding sites in peripheral tissues of the rat: implications for receptor-mediated immune modulation by cannabinoids. , 1994, The Journal of pharmacology and experimental therapeutics.

[24]  Ronald N. Germain,et al.  MHC-dependent antigen processing and peptide presentation: Providing ligands for T lymphocyte activation , 1994, Cell.

[25]  C. Janeway,et al.  Signals and signs for lymphocyte responses , 1994, Cell.

[26]  S. Munro,et al.  Molecular characterization of a peripheral receptor for cannabinoids , 1993, Nature.

[27]  P. Casellas,et al.  Cannabinoid-receptor expression in human leukocytes. , 1993, European journal of biochemistry.

[28]  C. Newton,et al.  Differing effects of delta-9-tetrahydrocannabinol (THC) on murine spleen cell populations dependent upon stimulators. , 1992, International journal of immunopharmacology.

[29]  Richard O. Hynes,et al.  Integrins: Versatility, modulation, and signaling in cell adhesion , 1992, Cell.

[30]  R. Bronson,et al.  Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene , 1991, Cell.

[31]  M. Herkenham,et al.  Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[32]  T. Bonner,et al.  Structure of a cannabinoid receptor and functional expression of the cloned cDNA , 1990, Nature.

[33]  R. Germain,et al.  Monoclonal antibodies against the antigen receptor on a cloned T-cell hybrid. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[34]  K. McCoy,et al.  Delta9-tetrahydrocannabinol suppresses macrophage costimulation by decreasing heat-stable antigen expression. , 1998, International journal of immunopharmacology.

[35]  C. Newton,et al.  Cannabinoid receptors and the cytokine network. , 1998, Advances in experimental medicine and biology.

[36]  C. Watts,et al.  Capture and processing of exogenous antigens for presentation on MHC molecules. , 1997, Annual review of immunology.

[37]  Y. Daaka,et al.  Expression of cannabinoid receptor mRNA in murine and human leukocytes. , 1995, Advances in experimental medicine and biology.

[38]  P. Linsley,et al.  The role of the CD28 receptor during T cell responses to antigen. , 1993, Annual review of immunology.

[39]  M. Wiederhold,et al.  Effects of cannabinoids and cocaine on the mitogen-induced transformations of lymphocytes of human and mouse origins. , 1992, International journal of immunopharmacology.

[40]  T. Mustelin,et al.  Molecular events mediating T cell activation. , 1990, Advances in immunology.